News Coverage 03.10.20 Share on Twitter Share on Facebook Share on LinkedIn CRISPR-edited immune cells can survive and thrive after infusion into cancer patients Related Announcement, Patient Story Living Proof: Cancer Vaccine Recipients Bring Their Sto Research Update Cancer Vaccines: A New Era in Cancer Treatment Announcement, Press Release Dr. Sager Named Recipient of PICI’s Inaugural YIA Award